SPINEWAY, a company specialising in implants and surgical instruments for the treatment of vertebral (spinal) problems, is proud to announce that the Chinese company TINAVI Medical Technologies has joined its capital, following a €1.4 million increase in capital.
Following approval by the General Meeting on 4 November, Spineway increased its reserve capital through the issue of shares with attached warrants (Actions à Bons de Souscription d’Actions or ABSA in French) excluding preferential right of subscription, for a total of €1.4 million (including issue premium).This increase in capital, made on November 18 through the issue of 355,260 new shares with attached warrants, was paid for entirely by TINAVI Medical Technologies, which now holds 9.09% of the capital and 5.04% of Spineway’s voting rights.
Stéphane Le Roux, Chief Executive Officer of Spineway, says: “We are delighted to welcome TINAVI Medical Technologies into our capital. In keeping with our Skyway 2018 plan, this partnership will open great potential for our development in China, which is a key nation in our Group’s history. On top of that, the synergies between our areas of expertise and know-how will help our respective companies grow and develop more rapidly in the spinal surgery market, which is continually striving to innovate.”
About Spineway
Spineway, established by Stéphane Le Roux and Philippe Laurito in 2005, is an independent company which designs, develops and markets ranges of state-of-the-art surgical implants and ancillaries used at all levels in the spinal column (lumbar, thoracic and cervical). Spineway’s offer has historically been centred on the provision of gold-standard products meeting the clearly identified needs of international markets. The Spineway ranges allow over 80% of operating needs to be met. Rolled out via a network of 48 specialist distributors, Spineway products are now available in more than 40 countries. Recognised for its innovation and strong growth, Spineway was a Deloitte Fast 50 winner (2011), was awarded the OSEO Excellence award in 2011 and the INPI innovation award for Rhône-Alpes in 2013. The company was listed on the stock market for the first time on 13 February 2013 at the NYSE Alternext Paris under the symbol ALSPW.
Find out all about Spineway at www.spineway.com